Fust Matthew K - Insider Transactions
Insider Type
individual
Companies
3
Average
2,177,777
Total Txns
10
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 0 | 9 | -9 | 0.00 | 3,639,554.56 | -3,639,554.56 |
| 2025 | 0 | 1 | -1 | 0.00 | 716,000.00 | -716,000.00 |
| Total: | 0 | 10 | 10 | 0.00 | 4,355,554.56 | -4,355,554.56 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. Common Stock US22663K1079 |
44.75 USD |
16,000 Sold |
716,000 USD |
26/09/2025 | 26/09/2025 |
|
17.03 USD |
14,049 Sold |
239,319 USD |
17/10/2024 | 18/10/2024 | |
|
17.01 USD |
7,739 Sold |
131,643 USD |
17/10/2024 | 17/10/2024 | |
| Crinetics Pharmaceuticals, Inc. Common Stock US22663K1079 |
45.50 USD |
17,500 Sold |
796,250 USD |
20/03/2024 | 20/03/2024 |
| Crinetics Pharmaceuticals, Inc. Common Stock US22663K1079 |
43.57 USD |
12,500 Sold |
544,625 USD |
20/03/2024 | 20/03/2024 |
| Crinetics Pharmaceuticals, Inc. Common Stock US22663K1079 |
43.57 USD |
12,500 Sold |
544,625 USD |
20/03/2024 | 20/03/2024 |
| Crinetics Pharmaceuticals, Inc. Common Stock US22663K1079 |
43.58 USD |
17,500 Sold |
762,650 USD |
20/03/2024 | 20/03/2024 |
| Ultragenyx Pharmaceutical Inc. Common Stock IE000KHX9DX6 |
50.89 USD |
2,550 Sold |
129,770 USD |
07/03/2024 | 07/03/2024 |
| Ultragenyx Pharmaceutical Inc. Common Stock IE000KHX9DX6 |
50.85 USD |
2,145 Sold |
109,073 USD |
07/03/2024 | 07/03/2024 |
| Ultragenyx Pharmaceutical Inc. Common Stock IE000KHX9DX6 |
50.88 USD |
7,500 Sold |
381,600 USD |
07/03/2024 | 07/03/2024 |